Annual CFF
-$138.70 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, PBAX annual cash flow from financing activities is -$138.70 million
Performance
PBAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$5.42 M
-$5.94 M-1132.17%
September 30, 2023
Summary
- As of February 10, 2025, PBAX quarterly cash flow from financing activities is -$5.42 million, with the most recent change of -$5.94 million (-1132.17%) on September 30, 2023.
- Over the past year, PBAX quarterly CFF has dropped by -$5.42 million (-100.00%).
Performance
PBAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$143.60 M
-$5.42 M-3.92%
September 30, 2023
Summary
- As of February 10, 2025, PBAX TTM cash flow from financing activities is -$143.60 million, with the most recent change of -$5.42 million (-3.92%) on September 30, 2023.
- Over the past year, PBAX TTM CFF has dropped by -$143.60 million (-100.00%).
Performance
PBAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PBAX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -100.0% | -100.0% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
PBAX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | at low | -1132.2% | +2459.6% | <-9999.0% | at low |
5 y | 5-year | at high | at low | -1132.2% | +2459.6% | <-9999.0% | at low |
alltime | all time | at high | at low | -1132.2% | +2459.6% | <-9999.0% | at low |
Phoenix Biotech Acquisition Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2023 | - | -$5.42 M(-1132.2%) | -$143.60 M(+3.9%) |
Jun 2023 | - | $525.00 K(-100.4%) | -$138.18 M(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$138.70 M | -$138.70 M(<-9900.0%) | -$138.70 M(<-9900.0%) |
Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2022 | - | $0.00 | $0.00 |
FAQ
- What is Phoenix Biotech Acquisition annual cash flow from financing activities?
- What is the all time high annual CFF for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition quarterly CFF year-on-year change?
- What is Phoenix Biotech Acquisition TTM cash flow from financing activities?
- What is the all time high TTM CFF for Phoenix Biotech Acquisition?
- What is Phoenix Biotech Acquisition TTM CFF year-on-year change?
What is Phoenix Biotech Acquisition annual cash flow from financing activities?
The current annual CFF of PBAX is -$138.70 M
What is the all time high annual CFF for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high annual cash flow from financing activities is -$138.70 M
What is Phoenix Biotech Acquisition quarterly cash flow from financing activities?
The current quarterly CFF of PBAX is -$5.42 M
What is the all time high quarterly CFF for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high quarterly cash flow from financing activities is $525.00 K
What is Phoenix Biotech Acquisition quarterly CFF year-on-year change?
Over the past year, PBAX quarterly cash flow from financing activities has changed by -$5.42 M (-100.00%)
What is Phoenix Biotech Acquisition TTM cash flow from financing activities?
The current TTM CFF of PBAX is -$143.60 M
What is the all time high TTM CFF for Phoenix Biotech Acquisition?
Phoenix Biotech Acquisition all-time high TTM cash flow from financing activities is $0.00
What is Phoenix Biotech Acquisition TTM CFF year-on-year change?
Over the past year, PBAX TTM cash flow from financing activities has changed by -$143.60 M (-100.00%)